• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Genmab Completes Acquisition of Merus N.V. for $97 per Share
06:35
Nov17
Merus N.V. Signs Non-exclusive Collaboration and License Agreement with Halozyme Therapeutics
13:18
Nov12
Merus N.V. to Hold Extraordinary Shareholders Meeting to Consider Genmab Acquisition Proposal
13:48
Nov10
Genmab A/S plans to issue notes and launch loans to raise funds for acquisition of Merus
12:16
Nov6
Genmab plans to acquire Merus for $800 million in a cash deal
16:02
Nov3
Goonewardene Analyzes Healthcare Company Stocks
18:21

Schedules & Filings

Schedules
Filings
Oct31
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.15 M, Net Income -95.52 M, EPS -1.2622

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 8.828 M, Net Income -158.22 M, EPS -2.2253

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 26.49 M, Net Income -96.47 M, EPS -1.3978

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More